NCT05752045 - OphtAI Diagnostic Performance Validation for Automated Screening of Eye Diseases | Biotech Hunter

Enrollment

1,389

Participants

Timeline

Start Date

June 28, 2023

Primary Completion Date

October 31, 2023

Study Completion Date

March 31, 2024

Conditions

Diabetic RetinopathyDiabetic Macular EdemaAge-Related Macular DegenerationAge-related MaculopathyGlaucoma

Interventions

DEVICE

Eye Fundus Double Capture for Eye Diseases Screening with OphtAI Medical Device

Double ophthalmological imaging capture of eye fundus with different fundus camera to screen patient for various eye diseases.

Trial Locations (12)

13090

RECRUITING

Centre Aix Vision, Aix-en-Provence

31059

RECRUITING

Diabète Occitanie, Toulouse

44000

ACTIVE_NOT_RECRUITING

CHU Nantes, Nantes

75000

NOT_YET_RECRUITING

OPHDIAT, Paris

90380

NOT_YET_RECRUITING

Retinodiab Franche-Comté, Roppe

91100

RECRUITING

CH SUD Francilien Corbeil Essonne, Corbeil-Essonnes

91220

RECRUITING

Centre Ophtalmologique Brétigny Essonne, Brétigny-sur-Orge

Unknown

RECRUITING

CHU Brest, Brest

RECRUITING

Centre d'examens de santé de la CPAM 93, Corbeil-Essonnes

RECRUITING

Retinodiab Bourgogne, Dijon

NOT_YET_RECRUITING

Clinique Honoré Cave, Montauban

RECRUITING

CHU Toulouse, Toulouse